CRISM Therapeutics Corporation Financial Flexibility Index
CRISM Therapeutics Corporation financial flexibility index. CRISM Therapeutics Corporation (CRTX) has a Financial Flexibility Index of -4.32x as of June 2026. Free cash flow of GBX-1.48 Million (operating CF GBX-1.48 Million minus capex GBX0.00) represents -4% of total liabilities (GBX343.00K).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of CRISM Therapeutics Corporation (2006–2025)
Financial flexibility index of CRISM Therapeutics Corporation from 2006 to 2025. Historical Financial Flexibility Index trend for CRISM Therapeutics Corporation across 20 annual periods. Check CRTX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CRISM Therapeutics Corporation Financial Flexibility Index by Year (2006–2025)
CRISM Therapeutics Corporation financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for CRISM Therapeutics Corporation. For the full cash flow conversion analysis, see CRISM Therapeutics Corporation (CRTX) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.08x | GBX-1.94 Million | GBX-1.97 Million | GBX381.00K | ▼ -91.5% |
| 2024 | -2.65x | GBX-905.00K | GBX-933.00K | GBX341.00K | ▲ +11.5% |
| 2023 | -3.00x | GBX-2.76 Million | GBX-2.77 Million | GBX920.19K | ▲ +29.4% |
| 2022 | -4.24x | GBX-3.25 Million | GBX-3.52 Million | GBX765.65K | ▼ -240.0% |
| 2021 | -1.25x | GBX-1.41 Million | GBX-1.83 Million | GBX1.13 Million | ▲ +28.6% |
| 2020 | -1.75x | GBX-1.84 Million | GBX-2.28 Million | GBX1.05 Million | ▲ +1.2% |
| 2019 | -1.77x | GBX-1.51 Million | GBX-1.90 Million | GBX852.24K | ▼ -864.9% |
| 2018 | -0.18x | GBX-507.29K | GBX-2.46 Million | GBX2.76 Million | ▼ -114.9% |
| 2017 | 1.23x | GBX1.16 Million | GBX-2.70 Million | GBX944.00K | ▲ +125.8% |
| 2016 | 0.55x | GBX2.12 Million | GBX-2.01 Million | GBX3.88 Million | ▲ +116.1% |
| 2015 | -3.39x | GBX-2.40 Million | GBX-2.99 Million | GBX709.20K | ▼ -13.7% |
| 2014 | -2.98x | GBX-1.21 Million | GBX-1.96 Million | GBX407.00K | ▲ +85.7% |
| 2013 | -20.81x | GBX-1.55 Million | GBX-1.62 Million | GBX74.25K | ▼ -385.8% |
| 2012 | -4.28x | GBX-313.65K | GBX-750.98K | GBX73.21K | ▲ +70.0% |
| 2011 | -14.26x | GBX-1.45 Million | GBX-2.67 Million | GBX102.00K | ▼ -240.2% |
| 2010 | -4.19x | GBX-459.55K | GBX-778.08K | GBX109.60K | ▼ -135.7% |
| 2009 | -1.78x | GBX-514.97K | GBX-843.95K | GBX289.43K | ▼ -141.1% |
| 2008 | 4.33x | GBX1.27 Million | GBX-2.06 Million | GBX292.12K | ▼ -61.1% |
| 2007 | 11.13x | GBX1.95 Million | GBX-692.47K | GBX175.32K | ▼ -46.2% |
| 2006 | 20.67x | GBX324.68K | GBX-998.08K | GBX15.71K | — |